Skip to main content

Dr Emyr Bakker

Lecturer in Medical Sciences
School of Medicine

Emyr teaches several subjects in the School of Medicine, primarily biochemistry and genetics, and leads a Level 6 research module (XY3040, The Principles and Application of Research). Emyr’s research background is in molecular oncology and computational biology, and he supervises research students at both the undergraduate and postgraduate level. His research team currently focuses on computational modelling of molecular cancer signalling pathways. Emyr is a Fellow (FHEA) with Advance HE and also holds a PGCTLHE.

Emyr has published a number of articles pertinent to cancer research, ranging from fundamental in vitro discoveries through to review articles discussing the state of clinical trials. Whilst most of his efforts have been on leukaemia and mesothelioma, since 2020 there has been increased focus on breast cancer. Emyr leads a research team all employing computational approaches to investigate cancer cell signalling and Emyr holds a number of internal and external research collaborations, frequently with The University of Manchester and The University of Salford. In addition to this, Emyr has also published a lead author chapter in the 2019 clinical guidebook for mesothelioma.

As of June 2020, Emyr is also a member of Brain Tumour North West. In terms of teaching, Emyr leads the Level 6 XY3040 module (The Principles and Application of Research) on the Master's in Physician Associate Studies (MPAS) degree for which he is also the Deputy Course Lead. Emyr teaches biochemistry, genetics, and oncology to the MBBS, MPAS, and MSc Physician Associate Practice, as well as devoting significant time to teaching research and evidence-based medicine. Emyr greatly enjoys teaching and was awarded Best Postgraduate Teacher at Salford University in 2017. He has several years of experience in supervising and mentoring junior research scientists such as project students. Emyr is actively involved in student recruitment, and takes a lead on MPAS admissions whilst also participating in outreach and widening participation activities, along with undertaking international recruitment. 

Prior to joining UCLan in December 2017, Emyr completed a PhD under the supervision of Professor Marija Krstic-Demonacos at The University of Salford. Here, he employed an interdisciplinary approach of computational biology and wet laboratory methodologies to investigate mechanisms of microenvironment-induced chemotherapy resistance in paediatric leukaemia, whilst also dedicating a focus to elucidating causes of glucocorticoid hormone resistance.

Part of his research was to build predictive models that aimed to predict changes to molecular networks following loss-of-function mutations, and which also aimed to predict a patient’s response to chemotherapy. This was published in PLOS Computational Biology, recognised as one of the top journals in Bioinformatics and Computational Biology. After his PhD, Emyr worked on a project funded by the British Lung Foundation, where he investigated the role of hypoxia-related microRNAs in mesothelioma (a very rare cancer that is heavily tied to asbestos exposure). This research is ongoing via collaboration. Emyr left this position to join UCLan's School of Medicine as a Lecturer in Medical Sciences.

  • Postgraduate Certificate in Teaching and Learning in Higher Education, UCLan, 2020
  • PhD Biological Sciences (Cancer Research), The University of Salford, 2017
  • BSc (Hons) Genetics, The University of Manchester, 2012
  • Best Postgraduate Teacher (University of Salford), 2017

Modules Taught

  • UM1010 - Integrated Science and Clinical Medicine 1
  • UM2010 - Integrated Science and Clinical Medicine 2
  • XY3040 - The Principles and Application of Research
  • UM4001 - Medical Knowledge, Skills and Behaviours for Patient Care 1
  • Medical Education
  • Molecular Oncology
  • Computational Biology
  • Molecular Endocrinology
  • Clinical Trials
  • Fellow (FHEA) of Advance HE
  • Peer Reviewer For Journals Such As Journal of Translational Medicine and ecancermedicalscience, the journal of the European Institute of Oncology.